Atlas Trials

Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic Steatohepatitis

Clinical trial NCT06160271 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06160271
Sponsor
Central Hospital, Nancy, France
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-alcoholic Steatohepatitis
Start date
2024-09-01
Primary completion
2026-09-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.